Company Filing History:
2 out of 3,559 
2 out of 4,872 
Years Active: 2013-2025
Title: Michel Leonetti: Innovator in Molecular Complexes for Vaccination
Introduction
Michel Leonetti is a notable inventor based in Nozay, France. He has made significant contributions to the field of molecular complexes, particularly in the context of targeting antigens for vaccination purposes. With a total of 4 patents to his name, Leonetti's work is paving the way for advancements in immunology.
Latest Patents
Leonetti's latest patents include a molecular complex designed for targeting antigens towards cells. This invention involves a complex that comprises at least one antigen associated with two ligands of surface molecules. The first ligand is a sulphated sugar from the glycosaminoglycan family, while the second ligand is a specific surface molecule of the target cells. The first ligand is covalently bonded with the antigen and/or the second ligand, enhancing the efficacy of the vaccination process.
Career Highlights
Throughout his career, Michel Leonetti has worked with prestigious organizations such as the Commissariat à l'Énergie Atomique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these institutions has allowed him to develop innovative solutions in the field of molecular biology and vaccination.
Collaborations
Leonetti has collaborated with talented individuals in his field, including Alexandra Savatier and Adeline Gadzinski. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Michel Leonetti's work in molecular complexes for vaccination represents a significant advancement in the field of immunology. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific research.